Analysis Metabolite Name Measured Value Units CASE_CONTROL Chemotherapy Drug Race TIMEPOINT Tamoxyfen Taxane
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+2073Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+3271Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+3497Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4173Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4218Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4248Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4260Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4277Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4333Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4471Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4505Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4655Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4670Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4844Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4849Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4879Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+4941Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5032Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5091Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5112Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5212Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5234Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5307Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5389Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5452Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5465Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5495Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5656Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5662Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5717Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5758Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5777Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5833Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+5960Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6090Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6117Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6180Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6198Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6219Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6259Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6264Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6285Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6444Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6476Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6493Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6678Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6680Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6710Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6824Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6916Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+6918Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7210Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7269Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7293Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7504Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7689Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7723Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7738Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7776Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+7780Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+8056Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+8132Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+8471Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+8600Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+9125Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+9222Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+9394Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+9770Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+10125Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+10554Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+10664Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+10787Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+11196Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+11237Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+11483Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+11824Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+11992Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+12750Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+12751Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+13484Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+13486Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+13570Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+13658Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+13875Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+13910Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+14044Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+14283Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+15016Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+15226Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+15744Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+15892Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+16623Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+16762Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+17443Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+18031Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+20646Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+34927Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]2064Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]2481Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]4965Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODED-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O]Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+2073Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+2455Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+3384Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+3497Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4173Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4218Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4248Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4260Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4277Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4333Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4505Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4601Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4655Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4670Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4844Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4849Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4879Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+4941Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5032Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5091Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5112Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5212Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5234Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5300Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5307Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5352Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5389Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5452Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5465Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5495Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5639Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5717Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5758Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5777Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5833Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+5960Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6090Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6117Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6180Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6219Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6259Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6264Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6285Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6331Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6444Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6476Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6493Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6678Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6710Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6824Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEL-ORNITHINE (CAS# 70-26-8); (M+H)+6880Peak areaCase N Exemestane White Baseline N N

Return to search page
  logo